SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Johnnie W. who wrote (1096)2/24/1998 8:57:00 AM
From: Premier  Respond to of 2068
 
KKR, the ruthless characters, are out. Is it because they wanted to fork out smaller part of the pie than Payson wanted? Is it good or bad for Oxford? The answer will be found in actual outcome of negotiations with remaining parties. As an example, issuing lower equity for more money will be favorable to Oxford.

I will add to my long position @18 7/16, if opportunity is presented.

Premier



To: Johnnie W. who wrote (1096)2/24/1998 8:58:00 AM
From: DRRISK  Read Replies (1) | Respond to of 2068
 
WSJ reported that deal to be finished this week. I do not read NY Times? Would appreciate clarification I have heard nothing on CNBC but maybe I missed it.
DrRisk


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News